Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys.
Is the IL-10 Promoter Polymorphism at Position -592 Associated with Immune System-Related Diseases?
Quantitative oxygen extraction fraction from 7-Tesla MRI phase: reproducibility and application in multiple sclerosis.
Coordinated Gene Expression of Neuroinflammatory and Cell Signaling Markers in Dorsolateral Prefrontal Cortex during Human Brain Development and Aging.
Neurochemistry of Hypomyelination Investigated with MR Spectroscopy.
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients.
Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis.
[New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimode].
Visualizing iron in multiple sclerosis.
Effects of multiwalled carbon nanotubes on electrospun poly(lactide-co-glycolide)-based nanocomposite scaffolds on neural cells proliferation.
Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis.
Neuroborreliosis during natalizumab treatment in multiple sclerosis.
Molecular triggers of neuroinflammation in mouse models of demyelinating diseases.
Aquaporin-4 Autoantibodies in Neuromyelitis Optica: AQP4 Isoform-Dependent Sensitivity and Specificity.
[Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I)].
[Affective and psychotic disorders in multiple sclerosis].
Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination.
Prediction of antibody persistency from antibody titres to natalizumab.
Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance.
FRACTALKINE GENE RECEPTOR POLYMORPHISM IN PATIENTS WITH MULTIPLE SCLEROSIS.
Understanding Biomarkers of Neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding.
Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients.
Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus.
Low body weight linked to PML risk with natalizumab in MS
The use of telemedicine in patients with multiple sclerosis.
Pages
« first
‹ previous
…
294
295
296
297
298
299
300
301
302
…
next ›
last »